NEW YORK, Oct. 23 - Proteomics and pharmacogenomics firm Aspira Biosystems has won a Small Business Innovation Research grant from the National Institutes of Health, the company said on Tuesday.
According to South San Francisco, Calif.-based Aspira, the $108,000 award will help it develop a sequence-specific protein chip based on its ProteinPrint technology. This technology, the company said, allows researchers to create “synthetic cavities” that recognize and bind to specific amino-acid sequences.
The SBIR grant is the full amount the firm requested, Aspira said.